Antioxidant treatment enhances human mesenchymal stem cell anti-stress ability and therapeutic efficacy in an acute liver failure model

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zeng, Wen ^a,b   Xiao, Jia ^a,c,d   Zheng, Gang ^b   Xing, Feiyue ^c   Tipoe, George L ^d   Wang, Xiaogang ^c   He, Chengyi ^b   Chen, Zhi Ying ^b   Liu, Yingxia ^a  

^a SHENZHEN THIRD PEOPLE S HOSPITAL   (China)

^b SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^c JINAN UNIVERSITY   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT;

BIOLOGICAL MODEL; CYTOLOGY; DRUG EFFECTS; HUMAN; LIVER FAILURE, ACUTE; MESENCHYMAL STROMA CELL; PHYSIOLOGICAL STRESS;

ANTIOXIDANTS; HUMANS; LIVER FAILURE, ACUTE; MESENCHYMAL STROMAL CELLS; MODELS, BIOLOGICAL; STRESS, PHYSIOLOGICAL;

EID: 84930959840     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11100     Document Type: Article

References (46)

1. Keeffe E. B. Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology 120, 749-762 (2001).
2. van Poll D. et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47, 1634-1643 (2008).
3. Rountree C. B., Mishra L. & Willenbring H. Stem cells in liver diseases and cancer: recent advances on the path to new therapies. Hepatology 55, 298-306 (2012).
4. Tan C. Y. et al. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther 5, 76 (2014).
5. Wesson R. N. & Cameron A. M. Stem cells in acute liver failure. Adv Surg 45, 117-130 (2011).
6. Levine P. et al. Molecular mechanisms of stem cell therapy in alcoholic liver disease. Dig Liver Dis 46, 391-397 (2014).
7. Winkler S. et al. Human mesenchymal stem cells towards non-alcoholic steatohepatitis in an immunodeficient mouse model. Exp Cell Res 326, 230-239 (2014).
8. Zhang Z. & Wang F. S. Stem cell therapies for liver failure and cirrhosis. J Hepatol 59, 183-185 (2013).
9. Li Z., He C., Xiao J. & Chen Z. Treating end-stage liver diseases with mesenchymal stem cells: an oak is not felled at one stroke. OA Tissue Engin 1, 3 (2013).
10. Ryu K. H. et al. Tonsil-derived mesenchymal stem cells alleviate concanavalin A-induced acute liver injury. Exp Cell Res 326, 143-154 (2014).
11. Yuasa M. et al. Herpes simplex virus type 2 fulminant hepatitis after umbilical cord blood transplantation for acute myeloid leukemia. Rinsho Ketsueki 55, 682-686 (2014).
12. Dernbach E. et al. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 104, 3591-3597 (2004).
13. He T. et al. Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol 24, 2021-2027 (2004).
14. Drowley L. et al. Cellular antioxidant levels influence muscle stem cell therapy. Mol Ther 18, 1865-1873 (2010).
15. Zhou R. et al. Human umbilical cord mesenchymal stem cells and derived hepatocyte-like cells exhibit similar therapeutic effects on an acute liver failure mouse model. PLoS One 9, e104392 (2014).
16. Xiao J. et al. Tumor necrosis factor-alpha gene from mandarin fish, Siniperca chuatsi: molecular cloning, cytotoxicity analysis and expression profile. Mol Immunol 44, 3615-3622 (2007).
17. Xiao J. et al. Lycium barbarum polysaccharide attenuates alcoholic cellular injury through TXNIP-NLRP3 inflammasome pathway. Int J Biol Macromol 69, 73-78 (2014).
18. Bustin S. A. et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55, 611-622 (2009).
19. Xiao J. et al. Garlic-derived S-allylmercaptocysteine is a hepato-protective agent in non-alcoholic fatty liver disease in vivo animal model. Eur J Nutr 52, 179-191 (2013).
20. Liong E. C., Xiao J., Lau T. Y., Nanji A. A. & Tipoe G. L. Cyclooxygenase inhibitors protect D-galactosamine/lipopolysaccharide induced acute hepatic injury in experimental mice model. Food Chem Toxicol 50, 861-866 (2012).
21. Song P. et al. Human genome-specific real-time PCR method for sensitive detection and reproducible quantitation of human cells in mice. Stem Cell Rev 8, 1155-1162 (2012).
22. Li P. et al. PKH26 can transfer to host cells in vitro and vivo. Stem Cells Dev 22, 340-344 (2013).
23. Park M. et al. Tonsil-derived Mesenchymal Stem Cells Ameliorate CCl4-induced Liver Fibrosis in Mice via Autophagy Activation. Sci Rep 5, 8616 (2015).
24. Jones D. P. Redefining oxidative stress. Antioxid Redox Signal 8, 1865-1879 (2006).
25. Panigrahi G. K. et al. Hepatic transcriptional analysis in rats treated with Cassia occidentalis seed: Involvement of oxidative stress and impairment in xenobiotic metabolism as a putative mechanism of toxicity. Toxicol Lett 229, 273-283 (2014).
26. Itoh K., Tong K. I. & Yamamoto M. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 36, 1208-1213 (2004).
27. Francois S. et al. Human mesenchymal stem cells provide protection against radiation-induced liver injury by antioxidative process, vasculature protection, hepatocyte differentiation, and trophic effects. BioMed Res Int 2013, 151679 (2013).
28. Bhatia S. N., Underhill G. H., Zaret K. S. & Fox I. J. Cell and tissue engineering for liver disease. Sci Transl Med 6, 245sr242 (2014).
29. Chang W. et al. Anti-death strategies against oxidative stress in grafted mesenchymal stem cells. Histol Histopathol 28, 1529-1536 (2013).
30. Chen Y. T. et al. Melatonin treatment further improves adipose-derived mesenchymal stem cell therapy for acute interstitial cystitis in rat. J Pineal Res 57, 248-261 (2014).
31. Oshima H. et al. Differential myocardial infarct repair with muscle stem cells compared to myoblasts. Mol Ther 12, 1130-1141 (2005).
32. Kim Y. S., Pi S. H., Lee Y. M., Lee S. I. & Kim E. C. The anti-inflammatory role of heme oxygenase-1 in lipopolysaccharide and cytokine-stimulated inducible nitric oxide synthase and nitric oxide production in human periodontal ligament cells. J Periodontol 80, 2045-2055 (2009).
33. Zipper L. M. & Mulcahy R. T. Erk activation is required for Nrf2 nuclear localization during pyrrolidine dithiocarbamate induction of glutamate cysteine ligase modulatory gene expression in HepG2 cells. Toxicol Sci 73, 124-134 (2003).
34. Paul M. K. et al. Dynamic Changes in Intracellular ROS Levels Regulate Airway Basal Stem Cell Homeostasis through Nrf2-Dependent Notch Signaling. Cell Stem Cell 15, 199-214 (2014).
35. Ebert R. et al. Selenium supplementation restores the antioxidative capacity and prevents cell damage in bone marrow stromal cells in vitro. Stem Cells 24, 1226-1235 (2006).
36. Wang X. Q. et al. Decreased SIRT3 in aged human mesenchymal stromal/stem cells increases cellular susceptibility to oxidative stress. J Cell Mol Med 18, 2298-2310 (2014).
37. Kim I. D. & Ha B. J. The effects of paeoniflorin on LPS-induced liver inflammatory reactions. Arch Pharm Res 33, 959-966 (2010).
38. Loseva P. et al. Extracellular DNA oxidation stimulates activation of NRF2 and reduces the production of ROS in human mesenchymal stem cells. Expert Opin Biol Ther 12 Suppl 1, S85-97 (2012).
39. Huang Z., Li J., Zhang S. & Zhang X. Inorganic arsenic modulates the expression of selenoproteins in mouse embryonic stem cell. Toxicol Lett 187, 69-76 (2009).
40. Valle-Prieto A. & Conget P. A. Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cell Dev 19, 1885-1893 (2010).
41. Bai L. et al. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 15, 862-870 (2012).
42. Song Y. S. et al. Mesenchymal stem cells overexpressing hepatocyte growth factor (HGF) inhibit collagen deposit and improve bladder function in rat model of bladder outlet obstruction. Cell Transplant 21, 1641-1650 (2012).
43. Uccelli A., Moretta L. & Pistoia V. Mesenchymal stem cells in health and disease. Nature Rev Immunol 8, 726-736 (2008).
44. Francois S., Usunier B., Douay L., Benderitter M. & Chapel A. Long-Term Quantitative Biodistribution and Side Effects of Human Mesenchymal Stem Cells (hMSCs) Engraftment in NOD/SCID Mice following Irradiation. Stem Cell Int 2014, 939275 (2014).
45. Pervaiz S., Taneja R. & Ghaffari S. Oxidative stress regulation of stem and progenitor cells. Antioxid Redox Signal 11, 2777-2789 (2009).
46. Bernal W. & Wendon J. Acute liver failure. N Engl J Med 369, 2525-2534 (2013).